In The News Posted November 12, 2021 Share Posted November 12, 2021 NORWOOD, Mass., Nov. 12, 2021 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today provided corporate updates and reported financial results for the third quarter of 2021. Key Programs' Updates: Anti-integrin...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts